111 (YI) Tariff Resilience Score: 4/10 (As of Jul. 03, 2026)


YI 111 Inc YI
51 GF Score
Price $4.21
GF Value $6.66
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is 111 Tariff Resilience Score?

111 YI -0.24% 51 Tariff Resilience Score is 4 as of Jul. 03, 2026. GuruFocus rates YI with a GF Score™ of 51/100 and a GF Value™ of $6.66 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 119 Medical Distribution companies, 111 ranks better than 87.39% on this metric.

111 has the Tariff Resilience Score of 4, which implies that the company might have Average Resilient.

111 has 111 Inc relies heavily on international suppliers for its e-commerce platform, making it vulnerable to tariffs. Its primary market is China, but it imports many products, exposing it to trade tensions. Limited pricing power and few alternative suppliers increase its vulnerability.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes 111 might have Average Resilient.

111  (NAS:YI) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

111 Tariff Resilience Score Related Terms

YI vs COSM, HKPD, SNYR: Tariff Resilience Score Comparison

For the Medical Distribution subindustry, 111's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

111 Tariff Resilience Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, 111's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where 111's Tariff Resilience Score falls into.


YI
51GF Score
111 Inc YI
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 4 mean?
111 (YI) has a Tariff Resilience Score of 4 as of Jul. 03, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, 111 ranks #15 out of 119 companies in the Medical Distribution industry, placing it in the top 12.6%.
Is 111's Tariff Resilience Score too high?
111's current Tariff Resilience Score is 4. Based on the distribution chart, 111 ranks #15 out of 119 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, 111 has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does 111's Tariff Resilience Score compare to COSM and HKPD?
According to the Medical Distribution industry distribution chart, 111 ranks #15 out of 119 companies for Tariff Resilience Score. This places 111 in the top 13% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Distribution company?
A good Tariff Resilience Score depends on the Medical Distribution industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. 111's current Tariff Resilience Score is 4. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 111 stock overvalued right now?
Based on GuruFocus' analysis, 111 (YI) is currently considered Possible Value Trap. The stock's GF Value™ is $6.66, compared to a current price of $4.21 — trading 36.9% below its estimated fair value. The current Tariff Resilience Score is 4. 111's overall GF Score™ is 51/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For 111 (YI), the current Tariff Resilience Score is 4 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is 111 (YI) Overvalued in 2026?

Based on GuruFocus' analysis, 111 stock appears to be undervalued. The current stock price of $4.21 is trading 36.9% below its estimated GF Value™ of $6.66. GuruFocus considers 111 to be Possible Value Trap.

Key valuation signals for YI:

  • Tariff Resilience Score: 4
  • GF Value™: $6.66 vs. price of $4.21 (36.9% below fair value)
  • GF Score™: 51/100 with 3 warning signs

No single metric tells the full story. See the YI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

111 Business Description

Other Exchanges 811A:Germany
Address No.268 Yubei Road, 10th Floor, T1, Yuzhongxin, Pudong New Area, Shanghai, CHN, 201204
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.
51GF Score

Get the complete analysis for YI

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.21
Price
$6.66
GF Value